Skip to main content

Table 1 Descriptive characteristics

From: Secondary consent to biospecimen use in a prostate cancer biorepository

  N n (%)
Outcomes
 Does patient agree to allow study team to analyze other factors? 1931   
  Yes   1918 (99.33)
  No   13 (0.67)
 Consent for future use 1931   
  Yes always   197 (10.2)
  Yes conditional   1703 (88.19)
  Never   31 (1.61)
Predictors
 Age at diagnosis 1859   
Mean (SD)   61.03 (7.41)
 Race 1931   
  White   1682 (87.11)
  Black   237 (12.27)
  Other   12 (0.62)
 Family history of prostate cancer 1733   
  Yes   615 (35.49)
  No   1118 (64.51)
 Marital status 1322   
  Married   1133 (85.70)
  Separated/divorced/widowed   155 (11.72)
  Never married   34 (2.57)
 Employment status 1312   
  Employed   712 (54.27)
  Retired   530 (40.40)
  Unemployed   47 (3.58)
  Other   23 (1.75)
 Smoking status 1889   
  Never smoked   918 (48.60)
  Former smoker   753 (39.86)
  Current smoker   218 (11.54)
 Clinical stage 1881   
  T1c   1512 (80.38)
  T2a/T2b/T2c   369 (19.62)
 Gleason score 1888   
  2–6   1147 (60.75)
  7   587 (31.09)
  8+   154 (8.16)
\